Villanova Investment Management Co LLC Sells 31,210 Shares of Phibro Animal Health Co. (NASDAQ:PAHC)

Villanova Investment Management Co LLC lowered its stake in Phibro Animal Health Co. (NASDAQ:PAHC - Free Report) by 26.7% during the 3rd quarter, according to its most recent Form 13F filing with the SEC. The institutional investor owned 85,588 shares of the company's stock after selling 31,210 shares during the period. Phibro Animal Health makes up about 2.1% of Villanova Investment Management Co LLC's investment portfolio, making the stock its 18th largest holding. Villanova Investment Management Co LLC owned approximately 0.21% of Phibro Animal Health worth $1,927,000 as of its most recent filing with the SEC.

A number of other institutional investors and hedge funds also recently modified their holdings of the stock. Sofinnova Investments Inc. purchased a new position in shares of Phibro Animal Health in the second quarter worth approximately $3,975,000. Acadian Asset Management LLC grew its position in Phibro Animal Health by 6.3% during the 2nd quarter. Acadian Asset Management LLC now owns 717,506 shares of the company's stock worth $12,027,000 after purchasing an additional 42,299 shares in the last quarter. Algert Global LLC raised its stake in Phibro Animal Health by 521.1% during the 3rd quarter. Algert Global LLC now owns 71,335 shares of the company's stock valued at $1,606,000 after purchasing an additional 59,850 shares during the period. nVerses Capital LLC purchased a new stake in shares of Phibro Animal Health in the third quarter valued at $70,000. Finally, Dana Investment Advisors Inc. boosted its position in shares of Phibro Animal Health by 17.2% in the second quarter. Dana Investment Advisors Inc. now owns 513,926 shares of the company's stock worth $8,619,000 after buying an additional 75,546 shares during the period. Institutional investors and hedge funds own 99.34% of the company's stock.

Phibro Animal Health Stock Up 1.3 %

Shares of Phibro Animal Health stock traded up $0.29 during trading on Friday, hitting $23.21. 85,607 shares of the stock traded hands, compared to its average volume of 187,782. The stock has a market cap of $940.01 million, a P/E ratio of 53.98, a PEG ratio of 0.61 and a beta of 0.51. The company has a fifty day moving average price of $23.44 and a two-hundred day moving average price of $20.38. Phibro Animal Health Co. has a twelve month low of $10.03 and a twelve month high of $25.98. The company has a debt-to-equity ratio of 1.81, a quick ratio of 1.69 and a current ratio of 3.23.

Phibro Animal Health Dividend Announcement

The firm also recently announced a quarterly dividend, which will be paid on Wednesday, December 18th. Shareholders of record on Wednesday, November 27th will be given a $0.12 dividend. This represents a $0.48 annualized dividend and a yield of 2.07%. The ex-dividend date of this dividend is Wednesday, November 27th. Phibro Animal Health's dividend payout ratio is 111.63%.

Wall Street Analysts Forecast Growth

Several equities research analysts recently issued reports on PAHC shares. JPMorgan Chase & Co. started coverage on Phibro Animal Health in a research note on Tuesday, September 10th. They issued a "neutral" rating and a $22.00 price objective for the company. Barclays increased their price target on shares of Phibro Animal Health from $13.00 to $20.00 and gave the stock an "underweight" rating in a research report on Tuesday, November 12th. Bank of America boosted their price objective on shares of Phibro Animal Health from $13.00 to $15.00 and gave the company an "underperform" rating in a research report on Friday, August 30th. Finally, StockNews.com downgraded shares of Phibro Animal Health from a "strong-buy" rating to a "buy" rating in a research report on Friday. Three investment analysts have rated the stock with a sell rating, one has given a hold rating and one has issued a buy rating to the company. Based on data from MarketBeat, the stock presently has a consensus rating of "Hold" and a consensus target price of $16.50.

Phibro Animal Health Company Profile

Phibro Animal Health Corporation operates as an animal health and mineral nutrition company in the United States, Israel, Brazil, Ireland, and internationally. It operates through three segments: Animal Health, Mineral Nutrition, and Performance Products. The company develops, manufactures, and markets various products for food and companion animals including poultry, swine, beef and dairy cattle, aquaculture, and dogs.